American Journal of Ophthalmology
Volume 145, Issue 4 , Pages 635-638.e2 , April 2008

Effect of Topical Mitomycin C on Corneal Endothelium

  • Anita Panda

      Affiliations

    • Cornea, Ocular Surface Disease, and Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India
    • Corresponding Author InformationInquiries to Anita Panda, DII/33, Ansari Nagar, New Delhi, India 110029
    • ,
  • Jacob Pe’er

      Affiliations

    • Cornea, Ocular Surface Disease, and Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India
    • Department of Ophthalmology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel
    • ,
  • Anand Aggarwal

      Affiliations

    • Cornea, Ocular Surface Disease, and Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Hrishikesh Das

      Affiliations

    • Cornea, Ocular Surface Disease, and Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India
    • Department of Ophthalmology, B P Koirala Institute of Ophthalmology, Dharan, Nepal.
    • ,
  • Abhiyan Kumar

      Affiliations

    • Cornea, Ocular Surface Disease, and Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India
    • ,
  • Shalini Mohan

      Affiliations

    • Cornea, Ocular Surface Disease, and Refractive Surgery Services, Dr R P Centre, All India Institute of Medical Sciences, New Delhi, India

,Accepted 1 December 2007.

References 

  1. Lee GA, Hirst LW. Ocular surface squamous neoplasia. Surv Ophthalmol. 1995;39:429–450
  2. Panda A, Sharma N, Sen S. Frozen section guided excision of squamous cell carcinoma of conjunctiva and cornea. In:  Lass J editors. Advances in cornea. New York, New York: Plenum Press; 1998;p. 373–377
  3. Frucht-Pery J, Rozenmann Y. Mitomycin C therapy for corneal intraepithelial neoplasia. Am J Ophthalmol. 1994;117:164–168
  4. Tseng SH, Tsai YY, Chen FK. Successful treatment of conjunctival intraepithelial neoplasia with topical mitomycin C. Cornea. 1997;16:595–597
  5. Heigle TJ, Stulting RD, Palay DA. Treatment of recurrent conjunctival epithelial neoplasia with topical mitomycin C. Am J Ophthalmol. 1997;124:397–399
  6. Frucht-Pery J, Sugar J, Baum J, et al. Mitomycin C treatment for conjunctival-corneal intraepithelial neoplasia; a multicenter experience. Ophthalmology. 1997;104:2085–2093
  7. Wilson MW, Hungerford JL, George SM, et al. Topical mitomycin C for the treatment of conjunctival and corneal epithelial dysplasia and neoplasia. Am J Ophthalmol. 1997;124:303–311
  8. Akpek EK, Ertoy D, Kalayci D, et al. Postoperative topical mitomycin C in conjunctival squamous cell neoplasia. Cornea. 2002;21:12–16
  9. Haas K, BenDor D, Levartovsky S. Treatment of conjunctival corneal intraepithelial neoplasia with topical mitomycin C. Arch Ophthalmol. 1999;117:544–545
  10. Rozenman Y, Frucht-Pery J. Treatment of conjunctival intraepithelial neoplasia with topical mitomycin C. Cornea. 2000;19:1–6
  11. Kemp EG, Harnett AN, Chatterjee S. Preoperative topical and intraoperative local mitomycin C adjuvant therapy in the management of ocular surface neoplasia. Br J Ophthalmol. 2002;86:31–34
  12. Fucht-Perry J, Rozenman Y, Pe’er J. Topical mitomycin C for partially excised conjunctival squamous cell carcinoma. Ophthalmology. 2002;109:548–552
  13. Shields CL, Naseripour M, Shields JA. Topical mitomycin C for extensive, recurrent conjunctival-corneal squamous cell carcinoma. Am J Ophthalmol. 2002;133:601–606
  14. Prabhasawat P, Tacinvorakup P, Tesavibul N, et al. Topical 0.02% mitomycin C for the treatment of conjunctival and corneal intraepithelial neoplasia and squamous cell carcinoma. Cornea. 2005;24:443–448
  15. Midena E, Angelia CD, Valenti M, et al. Treatment of conjunctival squamous cell carcinoma with topical 5-Fluorouracil. Br J Ophthalmol. 2000;84:268–272
  16. Yamamoto N, Ohmura T, Suzuki H, et al. Successful treatment with 5-fluorouracil of conjunctival intraepithelial neoplasia refractive to mitomycin C. Ophthalmology. 2002;109:249–252
  17. Maskin SL. Regression of limbal epithelial dysplasia with topical interferon. Arch Ophthalmol. 1994;112:1145–1146
  18. Vann RP, Karp CL. Perilesional and topical interferon alpha-2b for conjunctival and corneal neoplasia. Ophthalmology. 1999;106:91–97
  19. Karp CL, Moore JK, Rosa RH. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Ophthalmology. 2001;108:1093–1098
  20. Schechter BA, Schrier A, Nagler RS, et al. Regression of presumed primary conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b. Cornea. 2002;21:6–11
  21. Pe’er J. Ocular surface squamous neoplasia. Ophthalmol Clin N Am. 2005;18:1–13
  22. Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf. 2003;2:66–73
  23. Belyea DA, Dan JA, Stamper RL, Lieberman MF, Spencer WH. Late onset of sequential multifocal bleb leaks after glaucoma filtration surgery with 5-fluorouracil and mitomycin C. Am J Ophthalmol. 1997;124:40–45
  24. Rubinfeld RS, Pfister RR, Stein RM, et al. Serious complications of topical mitomycin C after pterygium surgery. Ophthalmology. 1992;99:1647–1654
  25. Hayasaka S, Noda S, Yamamoto Y, Setogawa T. Postoperative installation of low-dose mitomycin C in the treatment of primary pterygium. Am J Ophthalmol. 1988;106:715–718
  26. Amano S, Motoyama Y, Oshika T, et al. Comparative study of intraoperative mitomycin C and beta irradiation in pterygium surgery. Br J Ophthalmol. 2000;84:618–621
  27. Schraermeyer U, Diestelhorst M, Bieker A, et al. Morphologic proof of the toxicity of mitomycin C on the ciliary body in relation to different application methods. Graefes Arch Clin Exp Ophthalmol. 1999;237:593–600
  28. Mietz H, Addicks K, Diestelhorst M, Krieglstein GK. Extraocular application of mitomycin C in a rabbit model: cytotoxic effects on the ciliary body and epithelium. Ophthalmic Surg. 1994;25:240–244
  29. McKelvie PA, Daniell M. Impression cytology following mitomycin C therapy for ocular surface squamous neoplasia. Br J Ophthalmol. 2001;85:1115–1119
  30. Salomao DR, Mathers WD, Sutphin JE, Cuevas K, Folberg R. Cytologic changes in the conjunctiva mimicking malignancy after topical mitomycin C chemotherapy. Ophthalmology. 1999;106:1756–1760
  31. Dudney BW, Malecha MA. Limbal stem cell deficiency following topical mitomycin C treatment of conjunctival-corneal intraepithelial neoplasia. Am J Ophthalmol. 2004;137:950–951
  32. Panda A, Venkateswarlu K, Angra SK, Mohan M. Changes in the corneal endothelial cell count as a function of age. Indian J Ophthalmol. 1985;33:221–223
  33. Ventura AC, Walti R, Bohnke M. Corneal thickness and endothelial density before and after cataract surgery. Br J Ophthalmol. 2001;85:18–20
  34. Lai LJ, Chen YF, Wu S, Tsao YP, Tsai RJ. Long-term evaluation of endothelial cell loss after phacoemulsification. Eur J Ophthalmol. 2002;12:30–33
  35. Lesiewska-Junk H, Kaluzny J, Malukiewicz-Wisniewska G. Endothelial cell loss induced by phacoemulsification occurs through apoptosis. Chang Gung Med J. 2001;24:621–627
  36. Sihota R, Sharma T, Agarwal HC. Intraoperative mitomycin C and the corneal endothelium. Acta Ophthalmol Scand. 1998;76:80–82
  37. Morales AJ, Zadok D, Mora-Retana R, Martinez-Gama E, Robledo NE, Chayet AS. Intraoperative mitomycin and corneal endothelium after photorefractive keratectomy. Am J Ophthalmol. 2006;142:400–404

PII: S0002-9394(07)01012-4

doi: 10.1016/j.ajo.2007.12.004

American Journal of Ophthalmology
Volume 145, Issue 4 , Pages 635-638.e2 , April 2008

Article Tools

* Image Usage & Resolution